BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• 

  FDA

  Analysts Cheer As Amgen Nabs Long-Awaited FDA Approval of Heart Failure Drug Corlanor

  April 16, 2015

   · 

  2 min read
• 

  Business

  Ex-Teva CEO Becomes Chief of Start-Up Ovid Therapeutics As Orphan Drugs Come Into Focus

  April 16, 2015

   · 

  3 min read
• Job Trends

  Cambridge Consultants to Create 100 Transatlantic Jobs

  April 16, 2015

   · 

  2 min read
• Business

  Medytox Solutions Announces Results For The Year Ended December 31, 2014

  April 16, 2015

   · 

  6 min read
• Business

  Ovid Appoints Dr. Jeremy Levin As Chief Executive Officer

  April 16, 2015

   · 

  1 min read
• Business

  AIT Bioscience Names Terri Pascarelli As New CEO

  April 16, 2015

   · 

  1 min read
• Policy

  Juniper Pharma Services Obtains Specials Licence

  April 16, 2015

   · 

  3 min read
• Genetown

  BioAegis Therapeutics Completes Initial $8 Million Convertible Note Round; Round Oversubscribed

  April 16, 2015

   · 

  3 min read
• Business

  Autifony Therapeutics Announces £3.3 Million Collaboration To Progress First-In-Class Drug For Schizophrenia Into Clinical Trials

  April 16, 2015

   · 

  6 min read
• FDA

  Momenta Announces FDA Approval Of ANDA For Glatopa (Glatiramer Acetate Injection), The First Substitutable Generic For COPAXONE (Glatiramer Acetate Injection) 20mg

  April 16, 2015

   · 

  5 min read